Neoadjuvant chemotherapy in bulky stage ib-iia cervical cancer: results of a quick course with vincristine, bleomycin, and cisplatin

International Journal of Gynecological Cancer

Volumn 19, Issue 1, 2009, Pages 50-53

  Ki, Kyung Do ^a   Song, Dong Hwa ^a   Tong, Seo Yun ^a   Lim, Myong Cheol ^a   Lee, Jong Min ^a   Lee, Seon Kyung ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Carcinoma; Cervix; Chemotherapy; Neoadjuvant; Survival

Indexed keywords

BLEOMYCIN; CISPLATIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GYNECOLOGY; HUMAN; LEUKOPENIA; LUNG FIBROSIS; LUNG TOXICITY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPHADENECTOMY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SKIN TOXICITY; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; ADJUVANT CHEMOTHERAPY; MIDDLE AGED; MORTALITY; PATHOLOGY; REGISTER; SURVIVAL; UTERINE CERVIX TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 65649146808     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGJ.0b013e318197f8be     Document Type: Article

References (32)

1. Shin HR, Jung KW, Won YJ, et al. 2002 Annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat. 2004;36:103-114.
2. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study. Gynecol Oncol. 1999;73:177-183.
3. Lai CH, Lin TS, Soong YK, et al. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma. Gynecol Oncol. 1989;35:193-198.
4. Curtin JP, Hoskins WJ, Venkatraman ES, et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol. 1996; 61:3-10.
5. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet. 1997;350:535-540.
6. Perez CA, Grigsby PW, Camel HM, et al. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys. 1995;31:703-716.
7. Sardi JE, Giaroli A, Sananes C, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage IB squamous carcinoma of the cervix: the final results. Gynecol Oncol. 1997;67:61-69.
8. Moore DH. Neoadjuvant chemotherapy for cervical cancer. Expert Opin Pharmacother. 2003;4:859-867.
9. Benedetti-Panici P, Scambia G, Greggi S, et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol. 1988;71:344-348.
10. Seoud M, Geara FB, Shamseddine A, et al. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables. Eur J Gynaecol Oncol. 2003;24:163-168.
11. De Pooter CM, Scalliet PG, Elst HJ, et al. Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation. Cancer Res. 1991;51:4523-4527.
12. Sardi J, Sananes C, Giaroli A, et al. Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol. 1993;49:156-165.
13. Chang TC, Lai CH, Hong JH, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol. 2000;18:1740-1747.
14. Chang HC, Lai CH, Chou PC, et al. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol. 1992;30: 281-285.
15. Napolitano U, Imperato F, Mossa B, et al. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (IB-IIIB): a long-term randomized trial. Eur J Gynaecol Oncol. 2003;24:51-59.
16. Serur E, Mathews RP, Gates J, et al. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol Oncol. 1997;65: 348-356.
17. World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication, Geneva, Switzerland, 1979. Out-of-print publication: http://whqlibdoc.who.int/publications/ 9241700483.pdf.
18. Moore DH. Treatment of stage IB2 (bulky) cervical carcinoma. Cancer Treat Rev. 2003;29:401-406.
19. Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179-188.
20. Huang HJ, Chang TC, Hong JH, et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (9/=4 cm) stage IB and IIA cervical carcinoma. Int J Gynecol Cancer. 2003;13:204-211.
21. Behtash N, Nazari Z, Ayatollahi H, et al. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer. Eur J Surg Oncol. 2006;32:1226-1230.
22. Eddy GL, Bundy BN, Creasman WT, et al. Treatment of (Bbulky[) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. 2007;106:362-369.
23. Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer. 2003;39:2470-2486.
24. Lai CH, Hsueh S, Chang TC, et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol. 1997;64: 456-462.
25. Porzio G, Ficorella C, Toro G, et al. Short-term weekly neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer. Tumori. 2001;87:25-26.
26. Singh KC, Agarwal A, Agarwal S, et al. 'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer. Gynecol Obstet Invest. 2004;58:109-113.
27. Benedet JL, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat. 2001;6:7-43.
28. Bloss JD, Lucci JA 3rd, DiSaia PJ, et al. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol Oncol. 1995;59:105-110.
29. Zanetta G, Lissoni A, Pellegrino A, et al. Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol. 1998;9:977-980.
30. Sugiyama T, Nishida T, Kumagai S, et al. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer. 1999;81:95-98.
31. Vallejo CT, Pérez JE, DomÍnguez ME, et al. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix. Am J Clin Oncol. 2000;23: 481-486.
32. Termrungruanglert W, Tresukosol D, Vasuratna A, et al. Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecol Oncol. 2005; 97:576-581.